The American Journal of Surgery
Volume 186, Issue 4 , Pages 337-343 , October 2003

The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast

Presented at the Fourth Annual Meeting of the American Society of Breast Surgeons, Atlanta, Georgia, April 30–May 4, 2003

  • Melvin J Silverstein, M.D.

      Affiliations

    • Keck School of Medicine, University of Southern California, Harold E. and Henrietta C. Lee Breast Center, USC/Norris Comprehensive Cancer Center, 1441 Eastlake Ave., Rm. 7415, Los Angeles, CA 90033, USA
    • Corresponding Author InformationCorresponding author.

Received 3 June 2003 ,Revised 21 June 2003

References 

  1. Silverstein MJ, Poller D, Craig P, et al.  A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267–2274
  2. Sposto R, Epstein M, Silverstein MJ. Predicting local recurrence in patients with ductal carcinoma in situ of the breast. In:  Silverstein MJ,  Recht A,  Lagios MD editor. Ductal carcinoma in situ of the breast. Philadelphia: Lippincott, Williams and Wilkins; 2002;p. 255–263
  3. Vicini F, Kestin L, Goldstein N, et al.  Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol. 2000;18:296–306
  4. Goldstein N, Vicini F, Kestin L, et al.  Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer. 2000;88:2552–2560
  5. Silverstein MJ, Lagios M, Craig P, et al.  The Van Nuys prognostic index for ductal carcinoma in situ. Breast J. 1996;2:38–40
  6. Silverstein MJ, Poller D, Waisman J, et al.  Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345:1154–1157
  7. Poller D, Silverstein MJ. The Van Nuys ductal carcinoma in situ classification (an update). In:  Silverstein MJ,  Recht A,  Lagios MD editor. Ductal carcinoma in situ of the breast. Philadelphia: Lippincott, Williams and Wilkins; 2002;p. 222–233
  8. Silverstein MJ, Barth A, Poller D, et al.  Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer. 1995;31A:1425–1427
  9. Silverstein MJ, Barth A, Waisman J, et al.  Predicting local recurrence in patients with intraductal breast carcinoma (DCIS). Proc Am Soc Clin Oncol. 1995;14:117
  10. Silverstein MJ, Lagios M, Groshen S, et al.  The influence of margin width on local control in patients with ductal carcinoma in situ (DCIS) of the breast. N Engl J Med. 1999;340:1455–1461
  11. Goldstein NS, Kestin L, Vicini F. Intraductal carcinoma of the breast (pathologic features associated with local recurrence in patients treated with breast-conserving therapy). Am J Surg Pathol. 2000;24:1058–1067
  12. Lagios M. Duct carcinoma in situ (pathology and treatment). Surg Clin North Am. 1990;70:853–871
  13. Lagios M, Westdahl P, Margolin F, et al.  Duct carcinoma in situ (relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures). Cancer. 1982;50:1309–1314
  14. Lagios M, Margolin F, Westdahl P, et al.  Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989;63:619–624
  15. Lagios M. Controversies in diagnosis, biology, and treatment. Breast J. 1995;1:68–78
  16. Bellamy C, McDonald C, Salter D, et al.  Noninvasive ductal carcinoma of the breast (the relevance of histologic categorization). Human Pathol. 1993;24:16–23
  17. Solin L, Fourquet A, McCormick B, et al.  Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys. 1994;30:3–9
  18. Poller D, Silverstein MJ, Galea M, et al.  Ductal carcinoma in situ of the breast (a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression). Mod Pathol. 1994;7:257–262
  19. Ottesen G, Graversen H, Blichert-Toft M, et al.  Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. Am J Surg Pathol. 1992;16:1183–1196
  20. Schwartz G. The role of excision and surveillance alone in subclinical DCIS of the breast. Oncology. 1994;8:21–26
  21. Zafrani B, Leroyer A, Fourquet A, et al.  Mammographically-detected ductal in situ carcinoma of the breast anaylyzed with a new classification. A study of 127 cases (correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity). Semin Diagnost Pathol. 1994;11:208–214
  22. Fisher E, Constantino J, Fisher B, et al.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Cancer. 1995;75:1310–1319
  23. Silverstein MJ. Predicting local recurrence in patients with ductal carcinoma in situ. In: Silverstein MJ, editor. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins, p 271–84
  24. Silverstein MJ. Prognostic factors and local recurrence in patient with ductal carcinoma in situ of the breast. Breast J. 1998;4:349–362
  25. Ashikari R, Hadju S, Robbins G. Intraductal carcinoma of the breast. Cancer. 1971;28:1182–1187
  26. Bradley S, Weaver D, Bouwman D. Alternative in the surgical management of in situ breast cancer. Am Surg. 1990;56:428–432
  27. Fentiman I, Fagg N, Millis R, et al.  In situ ductal carcinoma of the breast (implications of disease pattern and treatment). Eur J Surg Oncol. 1986;12:261–266
  28. Rosner D, Bedwani R, Vana J, et al.  Noninvasive breast carcinoma. Results of a national survey of the American College of Surgeons. Ann Surg. 1980;192:139–147
  29. Fisher B, Dignam J, Wolmark N, et al.  Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441–452
  30. Julien J, Bijker N, Fentiman I, et al.  Radiotherapy in breast conserving treatment for ductal carcinoma in situ (first results of EORTC randomized phase III trial 10853). Lancet. 2000;355:528–533
  31. Houghton J, George W. Radiotherapy and tamoxifen following complete excision of ductal carcinoma in situ of the breast. In:  Silverstein MJ,  Recht A,  Lagios MD editor. Ductal carcinoma in situ of the breast. Philadelphia: Lippincott, Williams and Wilkins; 2002;p. 453–458
  32. Solin L, Yeh I, Kurtz J, et al.  Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer. 1993;71:2532–2542
  33. Fisher E, Dignam J, Tan-Chiu E, et al.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17 (intraductal carcinoma). Cancer. 1999;86:429–438
  34. Recht A. Side effects of radiation therapy. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins; 1997;p. 347–352
  35. Solin L, Recht A, Fourquet A, et al.  Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma of the breast. Cancer. 1991;68:2337–2344
  36. Schwartz G, Finkel G, Carcia J, et al.  Subclinical ductal carcinoma in situ of the breast (treatment by local excision and surveillance alone). Cancer. 1992;70:2468–2474
  37. Silverstein MJ, Lagios M, Martino S, et al.  Outcome after local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol. 1998;16:1367–1373
  38. Solin L, McCormick B, Recht A, et al.  Mammographically detected, clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast conserving surgery and definitive breast irradiation. Cancer J Sci Am. 1996;2:158–165

PII: S0002-9610(03)00265-4

doi: 10.1016/S0002-9610(03)00265-4

The American Journal of Surgery
Volume 186, Issue 4 , Pages 337-343 , October 2003

Article Tools

* Image Usage & Resolution